News Round-Up
5 May 2025
The Australian state's tyrannical control over bodily autonomy during an 'emergency' was confirmed today by the Supreme Court as it dismissed a vaccine mandate challenge brought against the West Australian Police.
A new study from the Czech Republic confirms that Covid vaccines have around zero efficacy against death, with any apparent effect an illusion due to biases in the data, says epidemiologist Prof Eyal Shahar.
AstraZeneca has admitted in court for the first time that its Covid jab can cause a deadly blood clotting side effect, paving the way for payouts (footed by the taxpayer) of up to £20m.
The WHO's Dr. Hanna Nohynek testified in court that she advised her Government that vaccine passports were not needed but was ignored, despite explaining that the Covid vaccines did not stop virus transmission.
Up to half of excess deaths in American nursing homes were due to the impact of lockdowns and mitigation measures on frail residents rather than the virus, according to new analysis.
As former Minister Kwasi Kwarteng prepares to step down at the next election, Paul Hicks writes to him to suggest that now is the time to act without fear or favour on Net Zero, the vaccines and the WHO pandemic treaty.
A new peer-reviewed study has linked mRNA jabs to excess cancer deaths in Japan, with pancreatic, prostate and ovarian cancers showing excess deaths in both 2021 and 2022.
The NHS says informed consent requires us to be given all the information about what a treatment involves. When Dr Zoë Harcombe tried to get this info on the Covid vaccine, however, she received nothing but obfuscation.
The Covid vaccine rollout began within days of approval. But since the BioNTech factory was not operational until April, does that mean the early toxic 'blue' batches were all from Pfizer's US facility, asks Robert Kogon.
Australia has binned over 35% of its multi-billion dollar Covid vaccine supply, with only 26% of the 267.3 million doses purchased being administered and another 15% set to expire soon.
© Skeptics Ltd.